| Dr Michelle Cao, MD | |
|
8881 Fletcher Pkwy, Suite 105, La Mesa, CA 91942-3134 | |
| (858) 499-2600 | |
| (619) 462-9625 |
| Full Name | Dr Michelle Cao |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 8881 Fletcher Pkwy, La Mesa, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003129842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A113677 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sharp Rees-stealy Medical Group Inc | 8628972759 | 772 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.
When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.
Scientists have taken a significant step forward in the search to find effective new drug candidates for the treatment of motor neurone disease.
Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions Research Roadmap, with the advent of the first in a series of publications resulting from its Brain Trauma Blueprint framework program.
› Verified 5 days ago
| Entity Name | Sharp Rees-stealy Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285616177 PECOS PAC ID: 8628972759 Enrollment ID: O20031120000996 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.
When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.
Scientists have taken a significant step forward in the search to find effective new drug candidates for the treatment of motor neurone disease.
Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions Research Roadmap, with the advent of the first in a series of publications resulting from its Brain Trauma Blueprint framework program.
› Verified 5 days ago
| Entity Name | Form Health Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043835044 PECOS PAC ID: 0244641272 Enrollment ID: O20201124001275 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.
When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.
Scientists have taken a significant step forward in the search to find effective new drug candidates for the treatment of motor neurone disease.
Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions Research Roadmap, with the advent of the first in a series of publications resulting from its Brain Trauma Blueprint framework program.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Cao, MD 8881 Fletcher Pkwy, Suite 105, La Mesa, CA 91942-3134 Ph: (858) 499-2600 | Dr Michelle Cao, MD 8881 Fletcher Pkwy, Suite 105, La Mesa, CA 91942-3134 Ph: (858) 499-2600 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.
When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.
Scientists have taken a significant step forward in the search to find effective new drug candidates for the treatment of motor neurone disease.
Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions Research Roadmap, with the advent of the first in a series of publications resulting from its Brain Trauma Blueprint framework program.
› Verified 5 days ago
Dr. Vinh Duc Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2600 Fax: 619-644-6899 | |
Armdabi Chung, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10862 Calle Verde, La Mesa, CA 91941 Phone: 619-660-1826 | |
Jungook Devin Shin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8080 Parkway Dr, La Mesa, CA 91942 Phone: 800-290-5000 Fax: 800-290-5000 | |
Joseph P Aiello, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8875 La Mesa Blvd, La Mesa, CA 91942 Phone: 619-670-8028 | |
Ms. Paula Leibham, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5525 Grossmont Center Dr Ste 200, La Mesa, CA 91942 Phone: 619-644-6569 Fax: 619-644-6526 | |
Dr. Joseph Francis Leonard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5525 Grossmont Center Dr, Suite 200, La Mesa, CA 91942 Phone: 619-644-6500 Fax: 619-644-6526 |